Business Wire

Analyze Contracts Like a Lawyer - Wordsmith’s First Pass Unlocks Legal Insight for Everyone

8.11.2024 00:54:00 EET | Business Wire | Press release

Share

“Contracts often hold up business because legal teams are stretched too thin,” said Ross McNairn, CEO of Wordsmith. “First Pass allows anyone from the legal, commercial or other teams to quickly identify risks and key terms, helping move things forward.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108164624/en/

Wordsmith's First Pass lets you review contracts in minutes, not hours. (Graphic: Business Wire)

This is a glimpse at the future of legal AI agents. Taking a very specific task end-to-end and making it trivial for anyone to trigger.

Try It for Free

Users can access First Pass for free by creating an account at wordsmith.ai and then uploading the relevant agreement to the web, or simply email standard agreements—like NDAs—to nda@wordsmith.ai. Over the coming weeks, Wordsmith will be expanding this to many other agreement types.

End-to-End AI Analysis—More Than Just Contracting

What makes First Pass revolutionary is its AI-powered ability to handle the full process: from opening the email to classifying the document, analyzing key terms, flagging risks, marking up agreements, and preparing a follow-up—all without the need for special software. This makes it the fastest and simplest tool available for contract analysis.

Customizable for Your Team's Needs

For businesses that need tailored contract checks, Wordsmith provides advanced customization options. Teams can configure First Pass to flag specific risks or terms, with the option for legal teams to approve reviews where needed.

More Than Just Contract Review—A Suite of Productivity Tools

First Pass is just one of many powerful tools offered by Wordsmith. The platform also includes helpful features like full document translation for contracts in multiple languages, allowing businesses to handle international agreements with ease. Additionally, Wordsmith offers tools to auto-draft documents, respond to repetitive queries, and streamline workflows for maximum efficiency.

A New Era of Simple, Effective Contract Analysis

Tara Haig, the General Counsel from Multiverse, a European Unicorn, commented, “It understands nuanced legal language spread across different sections of agreements. The level of accuracy and detail is truly impressive.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20241108164624/en/

Contacts

Harris Grant | press@wordsmith.ai
General Media Info: Visit Wordsmith Press and Media -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.wordsmith.
ai%2Fpress-and-media&esheet=54148805&newsitemid=20241108164624&lan=en-US&anchor=
Wordsmith+Press+and+Media&index=2&md5=b70031d15cdaca76e9b30bd30c6204f7

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Transforming Africa’s Future Farmers: Satellite-Enabled IoT Powers Data-Driven Agribusinesses3.3.2026 09:50:00 EET | Press release

SES, a leading space solutions company, along with IoT technology provider Advannotech and additional service providers are collaborating to bring technology to South Africa’s next generation of farmers. The project would enable young farmers to get a feel for data-driven agribusiness while participating in the Enterprising Africa Regional Network (EARN), a hands-on program combining practical farming, business skills and innovation for success. The program aims to leverage technology to tackle food insecurity and economic growth through a climate-smart training farm in Centurion, South Africa and has successfully completed a three-month proof-of-concept trial. Using IoT over satellite and LoRaWAN (Long Range Wide Area Network) sensors, the project monitors soil moisture and temperature, water levels, and environmental factors such as light, CO₂, humidity and air temperature. Connected through SES satellites to a cloud-based backend, this system bypasses cellular networks to deliver co

Linnea Achieves CEP Certification for Cannabidiol Isolate3.3.2026 09:25:00 EET | Press release

Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP). The CEP serves to attest that the quality of an active pharmaceutical ingredient (API) is adequately controlled by the monographs of the European Pharmacopoeia, ensuring its safety, quality and conformity for use in medicinal products in Europe. Issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), the CEP represents an independent validation of consistency, safety, and regulatory compliance for the European market. This consequently simplifies the marketing authorization (MA) process for new medicines, as a detailed evaluation of the active substance by regulatory authorities is not required. This milestone represents a significant achievement for the company and reinforces its commitment to delivering consistent and high-quality cannabinoid ingredients. The certification provides customers and partners with as

Quectel Expands Small Cell Antennas Portfolio With Five New Products3.3.2026 09:00:00 EET | Press release

Quectel Wireless Solutions, a global end-to-end IoT solutions provider, has introduced five new small cell antennas to add further functionality and provide greater flexibility and choice for customers designing and implementing small cell deployments. The new antennas bring an additional range of form factors, mounting options and performance characteristics to the Quectel antenna range. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302915004/en/ Quectel expands small cell antennas portfolio with five new products “Whether you’re looking for an antenna to support critical wireless communications, dense stadium usage scenarios or ultimate capacity, these five new Quectel antennas have been designed to meet your needs,” says David Wei, Antenna Product Head, Quectel Wireless Solutions. “The new antennas augment our already comprehensive range of antennas, bring further choice and add capabilities for developers and enginee

Quectel Introduces FGH200M Wi-Fi HaLow Module for massive IoT Deployments3.3.2026 09:00:00 EET | Press release

Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of the FGH200M long range, low power Wi-Fi HaLow module. Based on the Morse Micro MM8108 chipset and operating in the sub-1GHz license exempt frequency band, the module delivers enhanced penetration and broader coverage, over a range of approximately 1km, while supporting low power consumption and large-scale device connectivity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302200601/en/ Quectel introduces FGH200M Wi-Fi HaLow module for massive IoT deployments The FGH200M module adopts the IEEE 802.11ah wireless networking protocol, also known as Wi-Fi HaLow, operating in the license-exempt Sub-1GHz spectrum. Designed to meet the evolving requirements of IoT connectivity, the FGH200M delivers extended Sub-1GHz signal coverage, enabling reliable device control at distances of up to one kilometer. “We’re excited to unveil th

Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 03:00:00 EET | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye